UnitedHealth xStock is projected to rise to $917.66 by 2027, a +117% move from its current price of $423.02. UNHX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $412.14 | $422.45 | $433.03 | -0.13% |
| Aug 3 | $407.39 | $421.89 | $436.90 | -0.27% |
| Aug 4 | $403.66 | $421.32 | $439.75 | -0.40% |
| Aug 5 | $400.45 | $420.75 | $442.08 | -0.54% |
| Aug 6 | $397.59 | $420.19 | $444.07 | -0.67% |
| Aug 7 | $394.97 | $419.63 | $445.83 | -0.80% |
| Aug 8 | $392.53 | $419.06 | $447.39 | -0.94% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $392.53 | $419.06 | $447.39 | -0.94% |
| Week 2 | $378.46 | $415.14 | $455.38 | -1.86% |
| Week 3 | $367.21 | $411.26 | $460.60 | -2.78% |
| Week 4 | $357.45 | $407.41 | $464.36 | -3.69% |
| Week 5 | $348.68 | $403.60 | $467.17 | -4.59% |
| Week 6 | $340.63 | $399.83 | $469.31 | -5.48% |
| Week 7 | $333.14 | $396.09 | $470.93 | -6.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
UnitedHealth xStock UNHX is a tokenized stock within the xStocks ecosystem. xStocks are tokenized stocks that are backed 1:1 by the underlying assets, compliant with EU regulations, accessible to non-US users, and provide a legal claim to the value of the stock. They are designed to be composable with DeFi protocols and can be integrated with other DeFi protocols like any other token.
xStocks enable easy access to 57 US Stocks and ETFs to regular users through top centralized and decentralized exchanges. This asset sits within that framework, offering exposure to UnitedHealth as a tokenized stock and supporting a regulated, broadly accessible investment vehicle.
As part of the tokenized assets ecosystem, UNHX represents UnitedHealth in a form designed for flexible access and regulatory compliance, aligning with the broader xStocks approach to tokenized real-world assets.
UNHX is currently priced at $423.61 and holds a market cap of $424.91K with a rank of 3686. The all-time high for UNHX is $440.04 and the all-time low is $234.96.
The forecast trajectory shows a path from a 2026 average of $423.61 toward higher prices in the long term. In 2027 the average is projected to be $917.66, rising further to $2,194.94 on average by 2030, and ultimately to $45,783.62 by 2050. The forecast paints a bullish picture for most future years, with expanding price bands and substantial upside relative to today.
Across years, projected ROI climbs from 0% in 2026 to magnitudes in the thousands by 2050, with an average price that grows from $423.61 in 2026 to $3,179.69 in the 2030s and well beyond in later decades. The sentiment in the forecast begins neutral in 2026 and becomes bullish from 2027 onward.
A major floor 33.1% below — a decisive break under it would weaken the trend.
The nearest floor, 12.0% below — buyers have tended to step in here.
The nearest ceiling, 3.2% above — a clean break opens room to run.
A major ceiling 12.3% above — clearing it would confirm fresh momentum.
Key UNHX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of UNHX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $428.81 | Sell | $424.84 | Sell |
| MA 10 | $418.78 | Buy | $420.98 | Buy |
| MA 20 | $414.33 | Buy | $414.40 | Buy |
| MA 50 | $398.96 | Buy | $397.67 | Buy |
| MA 100 | $364.27 | Buy | $375.06 | Buy |
| MA 200 | $338.68 | Buy | $351.64 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.23 | Neutral |
| Stoch RSI (14) | 46.57 | Neutral |
| CCI (20) | 69.30 | Neutral |
| Williams %R (14) | -37.36 | Info |
| MACD (12,26,9) | 0.77 | Buy |
| ROC (12) | 2.69 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 62.64 | Neutral |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | 25.19 | Buy |
| Ultimate (7,14,28) | 64.34 | Neutral |
| Momentum (10) | 6.76 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 432.28 | Sell |
| ADX (14) | 15.41 | Neutral |
| ATR (14) | 8.08 | Info |
The 30-day technical picture is bullish. RSI(14) is 60, indicating neutral-to-bullish momentum.
The 50-day simple moving average is $398.64 and the 200-day simple moving average is $338.60, placing the price above both averages on a mid-term horizon. Support is noted at $372.40 and resistance at $436.59, framing a near-term range as investors evaluate upside potential.
The 30-day range spans from $369.96 to $485.04, suggesting recent price action has traded within a broad band that could favor moves toward the resistance level if momentum persists.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $262.79 | $423.61 | $447.11 | 0% | Neutral | |
| $731.42 | $917.66 | $1,217.49 | +117% | Bullish | |
| $1,300.81 | $1,676.69 | $2,305.90 | +296% | Bullish | |
| $1,232.86 | $1,625.16 | $2,298.97 | +284% | Bullish | |
| $1,632.42 | $2,194.94 | $3,179.69 | +418% | Bullish | |
| $2,618.60 | $3,585.12 | $5,302.64 | +746% | Bullish | |
| $4,183.89 | $5,825.28 | $8,778.14 | +12.8x | Bullish | |
| $4,445.35 | $6,287.73 | $9,636.57 | +13.8x | Bullish | |
| $4,048.87 | $5,813.39 | $9,049.32 | +12.7x | Bullish | |
| $7,172.01 | $10,446.31 | $16,497.78 | +23.7x | Bullish | |
| $20,827.34 | $32,372.53 | $54,321.85 | +75.4x | Bullish | |
| $26,345.37 | $45,783.62 | $83,935.01 | +107.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $319.66 | $378.06 | $459.72 | -10.63% |
| September 2026 | $283.16 | $337.03 | $413.95 | -10.85% |
| October 2026 | $312.70 | $374.27 | $463.68 | +11.05% |
| November 2026 | $322.88 | $388.30 | $484.60 | +3.75% |
| December 2026 | $294.55 | $355.83 | $447.11 | -8.36% |
Click any year to see its month-by-month UNHX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect UNHX to range from $262.79 to $447.11 through 2026. The $423.61 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The UNHX price prediction for 2027 points to an average of $917.66 (low $731.42, high $1,217.49) — a potential gain of +117% on today's $423.02. Buyers look set to stay in control over this stretch.
In 2028, UNHX is projected to trade between $1,300.81 and $2,305.90, averaging $1,676.69 — a potential gain of +296% from today's $423.02. That is up +83% on the projected 2027 average. Momentum favours further upside here.
UnitedHealth xStock's 2029 outlook centres on $1,625.16, within a $1,232.86 to $2,298.97 range. That is -3% versus the projected 2028 average. That marks a +284% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, UNHX could reach as high as $3,179.69, with a base case around $2,194.94 and support toward $1,632.42 — roughly +418% from $423.02. Momentum favours further upside here.
Expect UNHX to range from $2,618.60 to $5,302.64 through 2031. The $3,585.12 average target implies a +746% move from current prices. That is up +63% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The UNHX price prediction for 2032 points to an average of $5,825.28 (low $4,183.89, high $8,778.14) — a potential gain of +12.8x on today's $423.02. Momentum favours further upside here.
In 2033, UNHX is projected to trade between $4,445.35 and $9,636.57, averaging $6,287.73 — a potential gain of +13.8x from today's $423.02. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
UnitedHealth xStock's 2034 outlook centres on $5,813.39, within a $4,048.87 to $9,049.32 range. That is -8% versus the projected 2033 average. That marks a +12.7x change versus current levels. Momentum favours further upside here.
By 2035, UNHX could reach as high as $16,497.78, with a base case around $10,446.31 and support toward $7,172.01 — roughly +23.7x from $423.02. Buyers look set to stay in control over this stretch.
Expect UNHX to range from $20,827.34 to $54,321.85 through 2040. The $32,372.53 average target implies a +75.4x move from current prices. That is up +210% on the projected 2035 average. Momentum favours further upside here.
The UNHX price prediction for 2050 points to an average of $45,783.62 (low $26,345.37, high $83,935.01) — a potential gain of +107.1x on today's $423.02. Buyers look set to stay in control over this stretch.
Investing $1,000 in UNHX today (≈ 2.363954 UNHX) could be worth
$108,230.39
+$107,230.39 (+10723%) by 2050 · US Dollar
Based on the average projected UNHX price of $45,783.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in UNHXwould be worth at today's price.
$1,000 invested in UNHX on Jul 30, 2025 (≈ 3.762248 UNHX) would be worth
$1,591.51
+$591.51 (+59.2%) today · 1.59× · US Dollar
Based on a UNHX entry price of $265.8 vs. today's $423.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $401.44 | $1,053.76 | +5.4% |
| 1 month ago | $374.42 | $1,129.81 | +13.0% |
| 3 months ago | $279.98 | $1,510.89 | +51.1% |
| 6 months ago | $336.07 | $1,258.72 | +25.9% |
| All time ago | $265.8 | $1,591.51 | +59.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our UNHX forecast.
Our base-case forecast reaches $850.00 around 2027.
Implied market cap at $850.00: $758.06K
Year-by-year forecasts show continued bullish momentum beyond 2026. The 2027 average is $917.66 with a max of $1,217.49 and a min of $731.42, yielding a 116.6% ROI on average. The 2028 forecast points to an average of $1,676.69 with a min of $1,300.81 and a max of $2,305.90, delivering a 295.8% ROI.
By 2030, the average rises to $2,194.94 (min $1,632.42, max $3,179.69) and a 418.1% ROI, with bullish sentiment continuing. The 2031–2035 horizon shows further gains, including a 2035 average of $10,446.31 (min $7,172.01, max $16,497.78) and a 2,366% ROI, followed by accelerating figures through 2040 ($32,372.53 average, max $54,321.85, 7,542.1% ROI) and 2050 ($45,783.62 average, max $83,935.01, 10,708% ROI).
These are estimates and not guarantees; actual results may differ. The forecast depicts a long-term bullish trajectory with substantial upside, but investors should consider that outcomes depend on multiple factors and market conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $2,194.94 with a min of $1,632.42 and a max of $3,179.69, and a forecasted ROI of 418.1%, with bullish sentiment.
The forecast project bullish sentiment from 2027 onward, with rising average prices and high ROI: 2027 avg $917.66 (ROI 116.6%), 2030 avg $2,194.94 (ROI 418.1%), and 2050 avg $45,783.62 (ROI 10,708%). These are estimates and not guarantees.
Yes. The 2027 max is $1,217.49 and the 2028 average is $1,676.69, indicating the asset could surpass $1,000 in the near term according to the forecast.
The current price is $423.61 and the market cap is $424.91K. The asset is ranked 3686.
The 30-day range is from a low of $369.96 to a high of $485.04.
UnitedHealth xStock Community Discussion
0Share your UnitedHealth xStock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.